CTSO Stock Analysis: Buy, Sell, or Hold?
CTSO - Cytosorbents Corp.
$0.58
0.04 (6.52%)
▲
5d:
-2.85%
30d:
-26.2%
90d:
-8.79%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 13, 2026
Get Alerted When CTSO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CTSO shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: CTSO shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CTSO is currently trading at $0.58, which is considered oversold relative to its 30-day fair value range of $0.61 to $0.77.
Technical Outlook: Technically, CTSO is showing sideways momentum. Immediate support is located at $0.50, while resistance sits at $0.75. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: CTSO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.25 (+800.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CTSO is showing sideways momentum. Immediate support is located at $0.50, while resistance sits at $0.75. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: CTSO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.25 (+800.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.61 -
$0.77
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.5%)
- BULLISH: Trading 800.5% below Wall St target ($5.25)
Fair Price Analysis
30-Day Fair Range
$0.61 -
$0.77
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.50
Resistance Level
$0.75
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.73
Wall Street Target
$5.25
(+800.5%)
Revenue Growth (YoY)
41.6%
Profit Margin
-22.1%
Share & Embed Analysis
Last updated: April 03, 2026 2:25 AM ET
Data refreshes hourly during market hours. Next update: 3:25 AM
Data refreshes hourly during market hours. Next update: 3:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTSO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 62 BUY |
|
PEN
Penumbra Inc |
STRONG BUY
18 analysts |
$360 | 58 HOLD |
